Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs

This publication has 23 references indexed in Scilit:

• Leukotriene modifiers for asthma treatment
  Clinical & Experimental Allergy, 2010
• Functional expression of cysteinyl leukotriene receptors on human platelets
  Platelets, 2010
• Dominant Expression of the CysLT₂Receptor Accounts for Calcium Signaling by Cysteinyl Leukotrienes in Human Umbilical Vein Endothelial Cells
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
• An alternative pathway for metabolism of leukotriene D₄: effects on contractions to cysteinyl‐leukotrienes in the guinea‐pig trachea
  British Journal of Pharmacology, 2001
• Characterization of the Human Cysteinyl Leukotriene 2 Receptor
  Journal of Biological Chemistry, 2000
• The Molecular Characterization and Tissue Distribution of the Human Cysteinyl Leukotriene CysLT2 Receptor
  Biochemical and Biophysical Research Communications, 2000
• BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes
  European Journal of Pharmacology, 1994
• In Vitro Antagonism of ONO-1078, a Newly Developed Anti-Asthma Agent, against Peptide Leukotrienes in Isolated Guinea Pig Tissues.
  The Japanese Journal of Pharmacology, 1992
• In Vivo Pharmacologic Profile of ONO-1078: A Potent, Selective and Orally Active Peptide Leukotriene (LT) Antagonist.
  The Japanese Journal of Pharmacology, 1992
• Versuchsanordnung zu Untersuchungen an der Bronchiàlmuskulatur
  Naunyn-Schmiedeberg's Archives of Pharmacology, 1940